BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Luo J, Wang X, Ma F, Kang G, Ding Z, Ye C, Pan Y, Zhao Y, Hong S, Chen J, Xi J, Wen S, Lin Y, Li X, Qiu L, Yang X, Li G, Yang J, Sun Q. Long-term immunogenicity and immune persistence of live attenuated and inactivated hepatitis a vaccines: a report on additional observations from a phase IV study. Clin Microbiol Infect 2019;25:1422-7. [PMID: 30496870 DOI: 10.1016/j.cmi.2018.11.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Peng XL, Cheng JS, Gong HL, Yuan MD, Zhao XH, Li Z, Wei DX. Advances in the design and development of SARS-CoV-2 vaccines. Mil Med Res 2021;8:67. [PMID: 34911569 DOI: 10.1186/s40779-021-00360-1] [Reference Citation Analysis]
2 Ma QQ, Wang HJ, Li J, Li MQ, Cao TS, Wu XY, Qiu HY, Zhao H, Qin CF. The infectivity and pathogenicity of Hepatitis A virus live-attenuated vaccine strain H2 in type I interferon receptor-deficient mice. Virol Sin 2022:S1995-820X(22)00123-7. [PMID: 35863604 DOI: 10.1016/j.virs.2022.07.009] [Reference Citation Analysis]
3 Wang X, Luo J, Ma F, Kang G, Ding Z, Pan Y, Zhao Y, Chen J, Feng K, Yan L, Zhang J, Li L, Lan Q, Li D, Yang X, Li G, Yang J, Sun Q. The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study. Front Cell Infect Microbiol 2021;11:672221. [PMID: 34222044 DOI: 10.3389/fcimb.2021.672221] [Reference Citation Analysis]
4 Chen S, Zhao Y, Yang Z, Li Y, Shi H, Zhao T, Yang X, Li J, Li G, Wang J, Ying Z, Yang J. The impact of different IPV-OPV sequential immunization programs on hepatitis A and hepatitis B vaccine efficacy. Hum Vaccin Immunother 2022;:1-6. [PMID: 35044877 DOI: 10.1080/21645515.2021.2024063] [Reference Citation Analysis]
5 Guo Y, Zhang L, Feng D, Zhao S, Liu Q, Xu J, Lu M, Li J, Zhang Y, Guo W. The impact of universal live attenuated hepatitis A vaccines in Henan, China, 2005-2018. Int J Infect Dis 2020;93:163-7. [PMID: 32045695 DOI: 10.1016/j.ijid.2020.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wang X, Pan Y, Chen J, Luo J, Xi J, Ye C, Zhao Y, Qiu L, Weng S, Hong S, Lin Y, Sun Q. The excretion rate and stability of HAAg in human fecal samples after live attenuated hepatitis A vaccination. J Med Virol 2020. [PMID: 32134114 DOI: 10.1002/jmv.25747] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Xiaojin S, Rodewald LE, Guomin Z, Hui Z, Ning M, Fuzhen W, Zundong Y. Long-term seropositivity, safety, and impact of inactivated and live, attenuated hepatitis a vaccines in China – A cross-sectional study. Vaccine 2020;38:8302-9. [DOI: 10.1016/j.vaccine.2020.11.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]